NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

By Matthew Bin Han Ong

NCI has launched a pilot study to assess whether assigning cancer patients treatment based on the genetic characteristics of their disease can improve outcomes for patients with advanced metastatic solid tumors.

NCI Clinical Trials Enrollment Drops to 17,500

By Paul Goldberg

Capitol Hill

GAO: FDA Data on Drug Shortages Inadequate

By Conor Hale

Duke's Victor Dzau Named IOM President

By Matthew Bin Han Ong

Recent Issues

Volume 50 | Issue 43 - November 15, 2024

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

NCI Clinical Trials Enrollment Drops to 17,500

GAO: FDA Data on Drug Shortages Inadequate

Duke's Victor Dzau Named IOM President

In Brief

NCI's John Czajkowski Takes Executive Dean Position At Harvard Medical School

Issam Markhoul named distinguished chair for hematology and oncology at University of Arkansas for Medical Sciences

Margaret Dimond named president of Karmanos Cancer Hospital

North Shore-LIJ Cancer Institute opens $47 million radiation facility

Duke-NUS Graduate Medical School Singapore partners with ImaginAb Inc.

St. Jude Thanks and Giving campaign rasies over $97 million

Roswell Park Cancer Institute to collaborate with GenomOncology

Roche Servicios S.A. and Cancer Genetics Inc. enter agreement

Novartis acquires CoStim Pharmaceuticals Inc.

Recent Issues

Renew today!

Subscriber content

Login